Education
About Us
Working with TipRanks
Follow Us
Karen DeHaan-Fullerton Insider Profile
4 Followers
Karen DeHaan-Fullerton, GC/Corporate Secy at Zomedica, holds 104.30K shares in Zomedica (Ticker: ZOMDF). Most recently, Karen DeHaan-Fullerton Bought $104,300 shares of Zomedica on May 20, 2025 for an estimated value of 4.17K.
Karen DeHaan-Fullerton has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Karen DeHaan-Fullerton's holdings
Insider Roles
GC/Corporate Secy
Roles that Karen DeHaan-Fullerton holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Karen DeHaan-Fullerton
Karen DeHaan-Fullerton's Trading History
List of latest transactions for each holding click on a transaction to see Karen DeHaan-Fullerton's performance on stock
You May Also Like
Karen DeHaan-Fullerton insider profile FAQ
What is the percentage of profitable transactions made by Karen DeHaan-Fullerton?
The percentage of profitable transactions made by Karen DeHaan-Fullerton is ―.
What is the average return per transaction made by Karen DeHaan-Fullerton?
The average return per transaction made by Karen DeHaan-Fullerton is ―.
What stocks does Karen DeHaan-Fullerton hold?
Karen DeHaan-Fullerton holds: ZOMDF stocks.
What was Karen DeHaan-Fullerton’s latest transaction?
Karen DeHaan-Fullerton latest transaction was an Informative Buy of $4.17K.
What was Karen DeHaan-Fullerton's most profitable transaction?
Karen DeHaan-Fullerton’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Karen DeHaan-Fullerton's role in Zomedica?
Karen DeHaan-Fullerton's role in Zomedica is GC/Corporate Secy.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.